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Abstract
Background: Microsomal stearoyl-CoA desaturase1 (SCD1) is the rate limiting enzyme involved in the
biosynthesis of monounsaturated fatty acids (MUFAs); palmitoleic (16:1) and oleic (18:1) acid from their
respective substrates palmitic (16:0) and stearic (18:0) acids. The ratio of 18:1 to 18:0 has been implicated
in the regulation membrane fluidity and function. SCD1 is abundantly expressed in obese humans as well
as rodent models. However, no studies have correlated the fatty acid desaturation index (16:1/16:0 and
18:1/18:0), an indicator of SCD1 activity with the markers of obesity in terms of body mass index (BMI)
and adiposity index (AI). Therefore, here, we attempted to relate the fatty acid desaturation index with
BMI and AI in Wistar NIN-obese mutant rat strains namely, WNIN/Ob and WNIN/GR-Ob (with impaired
glucose tolerance).
Methods: For this purpose, 200 days old male 6 lean and 6 obese rats of both strains were taken. Fatty
acid composition was analyzed in plasma, various tissues such as liver, white adipose tissues
(retroperitoneal, epididymal, omental, and subcutaneous) and brown adipose tissue.
Results: Fatty acid composition data showed significant increase in palmitoleic (16:1) and oleic (18:1) acid
levels, which were reflected in increased desaturation index (16:1/16:0 and 18:1/18:0) in plasma and all the
tissues of obese rats of both strains, when compared with their respective age and sex-matched lean rats.
Further, we found a strong positive correlation between desaturation index, BMI and AI in plasma and
most of the tissues analyzed.
Conclusion: So far, plasma Δ9 desaturation index has been well correlated with hypertriglyceridemia and
we, by employing two models of obesity namely, WNIN/Ob and WNIN/GR-Ob, have shown Δ9
desaturation index of plasma correlated with physical markers of obesity such as BMI and AI. In conclusion,
Δ9 desaturation index may serve as a potential sensitive biochemical marker to assess the degree of obesity
and impact of therapeutic/nutritional interventions to combat obesity, along with other indicators.
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Background
Obesity, arising out of modern lifestyle has attained the
status of "globesity" and affecting the health of millions of
people with various socio-economic consequences. Obes-
ity, a condition caused by imbalanced energy homeosta-
sis, manifests itself as excessive fat deposition and often
associated with several morbidities, such as type 2 diabe-
tes, hypertension, coronary heart disease, and certain
types of cancers, respiratory complications and osteoar-
thrites [1]. Microsomal stearoyl-CoA desaturase1 (SCD1)
is the rate limiting enzyme involved in the biosynthesis of
monounsaturated fatty acids (MUFA); palmitoleoyl and
oleoyl-CoAs from their respective substrates palmitoyl
and stearoyl-CoAs by Δ9-cis desaturation. These MUFAs
are major substrates for the synthesis of various lipids
such as phospholipids (PL), triglycerides (TG), cholesteryl
and wax esters. The ratio of stearic (18:0) to oleic (18:1)
acids has been implicated in the regulation of cell growth
and differentiation through effects on membrane fluidity
and signal transduction [2]. Recent studies have estab-
lished that SCD1 is the most highly expressed gene in
human and rodent models of obesity [3,4]. Further, it has
been shown that SCD1 determines the fate of energy,
whether it should go for storage or for oxidation [5].
Therefore, it appears that the SCD1 activity may be one of
the crucial factors that play a major role in the develop-
ment of obesity and its associated disorders.
Previously, Attie et al have reported a positive correlation
between the SCD1 activity, in terms of desaturation index
and plasma TG levels both in humans and mice [6]. Fur-
ther, another study by Mar-Heyming et al, wherein dysli-
pidemia has been shown to be positively correlated with
plasma desaturase index in patients of familial combined
hyperlipidemia [7]. However, so far, no study has related
the fatty acid desaturation index to physical markers of
obesity such as body mass and adiposity indices (BMI &
AI respectively). Therefore, here, we tried to address the
relationship between the fatty acid desaturation index, an
indicator of SCD1 activity, to BMI and AI of genetically
obese rats of Wistar NIN strains namely, WNIN/Ob and
WNIN/GR-Ob (with impaired glucose tolerance). The ori-
gin, physical and certain biochemical characteristics of
these rats strains are already described in our previous
publications [8,9].
Methods
Animals
200 days old 6 male rats of lean and obese phenotypes of
both WNIN/Ob and WNIN/GR-Ob (with impaired glu-
cose tolerance) strains were taken from stock colony fed
on standard pellet diet containing 4% ground nut oil
(composition of diet is given in table 1). Body weights
were recorded. After over-night fasting, blood was col-
lected from retro-orbital sinus for plasma separation. Rats
were killed after CO2 asphyxiation. Various tissues such as
liver, brown adipose tissue (BAT) and several white adi-
pose tissues (WAT) such as retroperitoneal (RPWAT),
epididymal (EWAT), subcutaneous (SWAT) and omental
(OWAT) were collected, weighed, frozen immediately and
stored at -80°C till further analysis.
Body Mass and Adiposity Indices
Body mass index (BMI) was calculated using the formula;
weight in Kg/body length in m2 [8]. Adiposity index was
determined by the sum of weights of white adipose tissues
divided by bodyweight × 100 and expressed as adiposity
percent [8].
Fast protein liquid chromatography (FPLC)-TG profile
Lipoprotein TG profile of pooled plasma sample (200 μl)
was obtained by fast protein liquid chromatography
(FPLC)-size fractionation as described earlier [9]. Triglyc-
eride concentration was determined by using commer-
cially available kits (BioSystems, Barcelona, Spain).
Lipid extraction and Gas Chromatography analysis
Total lipids were extracted from plasma and tissue sam-
ples, methylated and analyzed for fatty acid composition
by gas liquid chromatography as described earlier [10]. Δ9
desaturation index i.e. ratio of monounsaturated to satu-
rated fatty acids [palmitoleic to palmitic acid (16:1/16:0)
and oleic to stearic acid (18:1/18:0) ratios], the indicator
of SCD1 activity was calculated.
Statistics
SPSS software version 15.0 was used for statistical analy-
sis. Results were expressed as means ± SE of 6 animals
from each group. The mean values of body weight, BMI
and AI of lean and obese rats in different strains were com-
pared by student's t-test. The relationship of desaturation
index (16:0/16:1 & 18:0/18:1) of plasma and different tis-
sues with BMI and AI in a given strain was analyzed by
Spearman's non-parametric correlation analysis and P ≤
0.05 was considered significant.
Results
Body weight, AI and BMI
Table 2 shows that obese rats of both WNIN/Ob and
WNIN/GR-Ob strains had significantly higher body
Table 1: Composition of standard pellet diet
Ingredients g/100
Wheat flour 22.5
Roasted bengal gram flour 60
Skim milk powder 5
Casein 4
Refined groundnut oil 4
Salt mixture 4
Vitamin mixture 0.5Nutrition & Metabolism 2009, 6:27 http://www.nutritionandmetabolism.com/content/6/1/27
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weight, BMI and AI compared to their respective age and
sex-matched lean counterparts.
Desaturation Index of plasma and various tissues
Plasma, various white adipose tissues (RPWAT, EWAT,
SWAT and OWAT) and BAT of obese rats of both strains
showed higher Δ9 desaturation index as evidenced by ele-
vated 16:1 to 16:0 and 18:1 to 18:0 ratios compared to
their age and sex-matched lean rats (Figures 1a &1b and
2a &2b).
Plasma FPLC lipoprotein TG
To authentically confirm the over-expression of hepatic
SCD1 led to the hypertriglyceridemia, FPLC-plasma lipo-
protein fractionation was done and TG was analyzed. Fig-
ure 3. indicates the markedly elevated TG levels in VLDL
fraction of obese rats compared to their lean counterparts
of WNIN/Ob strain.
Correlation analysis
Non-parametric spearman's correlation analysis was per-
formed to establish the relationship between the Δ9 desat-
uration index, BMI and AI. Interestingly, in WNIN/Ob
strain, the fatty acid ratio 16:1 to 16:0 of plasma and all
the tissues showed a strong positive correlation with BMI
and AI.
Further, a significant correlation was also observed for the
ratio of 18:1 to 18:0 in plasma, RPWAT, EWAT, OWAT,
SWAT and BAT with BMI and AI, while in liver, this ratio
did not correlate with these parameters. The correlations
are presented in Table 3.
Unlike WNIN/Ob, in WNIN/GR-Ob strain, 16:1 to 16:0
ratio in plasma and all the tissue types analyzed signifi-
cantly correlated with BMI and AI; except OWAT, whose
ratio was not correlated with AI. Further, the ratio of 18:1
to 18:0 in plasma, liver, RPWAT, SWAT and OWAT
showed strong positive correlation with BMI, while other
tissues (EWAT and BAT) failed to show such correlation.
On the other hand, this ratio in plasma and various tissues
showed a strong positive relationship with AI (Table 4).
Discussion
SCD1 (Δ9 desaturase) is the rate limiting enzyme involved
in the biosynthesis of MUFA. In many species, different
isoforms of this SCD exist. In mice four isoforms; SCD1,
SCD2, SCD3 and SCD4, in rat two isoforms (SCD1,
SCD2) and in humans, two SCD isoforms have been iden-
tified and characterized [11,5]. SCD1-/--deficient mice
have defective hepatic TG and CE synthesis, despite the
normal activities of acyl CoA: cholesterol acyltransferase
(ACAT) and diacyl glycerol: acyltransferase (DGAT) (the
enzymes responsible for cholesterol ester and triglyceride
synthesis respectively) and the levels of palmitoleic (16:1)
and oleic (18:1) acids in plasma and tissue lipid fractions
are lower, whereas palmitic (16:0) and stearic (18:0) acid
levels are found to be higher than their wild type controls.
These observations suggest that endogenously synthe-
sized MUFAs by SCD1 are the main substrates for the syn-
thesis of hepatic TG and CE [12].
In agreement with the above-mentioned study, earlier, in
obese rats of WNIN/Ob strain, we reported significant
increase in the fatty acid desaturation index (16:1/16:0 &
18:1/18:0) (both serum and liver), and hypertriglyceri-
demia, which correlated well with the over-expression of
hepatic SCD1mRNA and protein compared to their age
and sex-matched lean rats [10]. Similar observations were
made even in obese rats of WNIN/GR-Ob strain [9].
Hence, it has been consistently demonstrated that hepatic
over-expression of SCD1 results in elevated TG levels and
increased desaturation index. In the present study, the
fatty acid desaturation index (both 16:1/16:0 & 18:1/
18:0) of obese rats was significantly high in plasma, liver,
various white adipose tissues and BAT of both WNIN/Ob
and WNIN/GR-Ob strains compared to their respective
lean mates, which clearly implies that the high expression
SCD1 could be responsible for this phenomenon.
Further, to confirm the fact that the SCD1 over-expression
leads to hypertriglyceridemia, TG levels in lipoprotein
fractions (carried out by FPLC) were estimated. Plasma
FPLC profile clearly showed an increase in VLDL-associ-
ated TG levels in obese rats compared to their lean coun-
terparts of WNIN/Ob strain. Therefore, the present data
unequivocally support that the over-expression of hepatic
SCD1 leads to increased TG and VLDL synthesis and secre-
tion and therefore, hypertriglyceridemia. Though, data on
plasma FPLC profile on WNIN/GR-Ob strain are lacking,
we do expect the similar pattern, as the obese rats of this
strain also exhibit hypertriglyceridemia. Interestingly,
sterculic acid, a cyclopropane fatty acid has been shown to
inhibit 90% of SCD1 enzyme activity due to reduced pro-
tein levels, which concomitantly resulted in decreased
palmitoleic (16:1) and oleic (18:1) acid levels in cultured
differentiating 3T3L1 adipocytes [13]. Therefore, collec-
Table 2: Body weight, BMI and AI of WNIN-mutant strain rats
WNIN/Ob WNIN/GR-Ob
Lean Obese Lean Obese
Body weight (g) 314 ± 15 736 ± 22* 433 ± 13 593 ± 22*
BMI 5.4 ± 0.2 10.4 ± 0.3* 6.5 ± 0.1 9.3 ± 0.5*
AI (%) 3.1 ± 0.4 21.8 ± 1.6* 2.5 ± 0.3 16.6 ± 1.0*
Values are means ± SE of 6 rats from each phenotypes. Lean and 
obese rats of each strain was compared and * denotes statistical 
significance at P ≤ 0.05 level (Student's t-test).Nutrition & Metabolism 2009, 6:27 http://www.nutritionandmetabolism.com/content/6/1/27
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Desaturation Index of plasma and various tissues of WNIN/Ob strain rats Figure 1
Desaturation Index of plasma and various tissues of WNIN/Ob strain rats. Values are mean ± SE of 6 rats from each 
phenotype. (a) 16:1/16:0 & (b) 18:1/18:0 fatty acid ratio of plasma, liver, various white adipose tissues (WAT) (RPWAT-retro-
peritoneal, EWAT-epidydimal, SWAT-subcutaneous & OWAT (Omentum) and BAT. *Statistically significant at p ≤ 0.05 level 
(Student's t-test).
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Desaturation Index of plasma and various tissues of WNIN/GR-Ob strain rats Figure 2
Desaturation Index of plasma and various tissues of WNIN/GR-Ob strain rats. Values are mean ± SE of 6 rats from 
each phenotype. (a) 16:1/16:0 & (b) 18:1/18:0 fatty acid ratio of plasma, liver, various white adipose tissues (WAT) (RPWAT-
retroperitoneal, EWAT-epididymal, SWAT-subcutaneous & OWAT-Omentum) and BAT. *Statistically significant at p ≤ 0.05 
level (Student's t-test).
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tive evidence from previous studies and the data of the
present study on the fatty acid desaturation index (16:1/
16:0 & 18:1/18:0) of various tissues of two obese rat
strains, clearly suggest the over-expression of SCD1 in
obesity.
SCD1 mRNA is highly expressed in white adipose tissue
(WAT), brown adipose tissue (BAT), meibomian gland,
harderian and preputial glands. This enzyme also serves as
a molecular marker for adipocyte differentiation. Some of
the recent studies brought out the role of SCD1 as a critical
metabolic control point in energy homeostasis, since the
activity of this enzyme determines whether the fatty acids
should be burnt for energy release or stored as triglycer-
ides [5]. Previously, Cohen et al have demonstrated the
crucial role of SCD1 in the regulation energy homeostasis
in ob/ob mice. Further, these authors have also shown the
repressive effect of leptin on SCD1 expression and there-
fore, obesity and its associated metabolic changes such as
hepatic steatosis in ob/ob mice. Based on these observa-
tions, the authors concluded SCD1 as a key player in
energy portioning and most of the metabolic effects of
leptin are possibly mediated through the suppression of
this enzyme [14]. These experimental data unequivocally
established SCD1 as one of the potent regulators of energy
homeostasis and obesity.
In obese condition, especially in humans, assessing the
extent of obesity is very crucial for proper metabolic man-
agement during weight loss program. Therefore, relating
the anthropometric measures of obesity such as BMI and
AI with the biochemical indicators would not only help in
assessing the degree of obesity but also the extent of met-
abolic changes with regard to hypertriglyceridemia and
metabolic syndrome. In a population-based cohort study,
Waresnjo et al have shown the altered serum fatty acid
composition due to SCD1 (Δ9), Δ5 and Δ6desaturase activ-
ities and its association with the metabolic syndrome and
thereby suggesting that altered serum fatty acid composi-
tion may predict the development of metabolic syndrome
Plasma-lipoprotein TG profile of WNIN/Ob strain rats by FPLC Figure 3
Plasma-lipoprotein TG profile of WNIN/Ob strain rats by FPLC. 200 μl of pooled plasma samples from obese and 
lean rats were size fractionated by FPLC. An aliquot of each fraction was analyzed for TG content. The concentration of TG is 
expressed as mg/dL plasma.
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Table 3: Correlation between desaturation index, BMI and AI of WNIN/Ob strain rats
WNIN/Ob 16:1/16:0
Plasma Liver RPWAT EWAT SWAT OWAT BAT
BMI Correlation coefficient .698 .680 .675 .888 .888 .875 .729
p value .025 .031 .032 .001 .001 .001 .017
AI Correlation coefficient .638 .754 .636 .879 .879 .794 .636
p value .047 .012 .048 .001 .001 .006 .048
18:1/18:0
Plasma Liver RPWAT EWAT SWAT OWAT BAT
BMI Correlation coefficient .809 .590 .837 .778 .778 .760 .839
p value .005 .073 .005 .008 .008 .011 .002
AI Correlation coefficient .842 .539 .867 .903 .903 .758 .842
p value .002 .108 .002 .000 .000 .011 .002
Spearman's non-paratmetric correlation analysis of 16:1/16:0 and 18:1/18:0 with BMI & AI. P ≤ 0.05 was considered significant.
Table 4: Correlation between desaturation index, BMI and AI of WNIN/GR-Ob strain rats
WNIN/GR-Ob 16:1/16:0
Plasma Liver RPWAT EWAT SWAT OWAT BAT
BMI Correlation coefficient .796 .685 .821 .827 .760 .921 .766
p value .002 .020 .004 .003 .011 .000 .010
AI Correlation coefficient .862 .618 .733 .855 .806 .617 .891
p value .000 .043 .016 .002 .005 .077 .001
18:1/18:0
Plasma Liver RPWAT EWAT SWAT OWAT BAT
BMI Correlation coefficient .821 .854 .762 .608 .750 .711 .539
p value .004 .003 .028 .062 .020 .032 .168
AI Correlation coefficient .745 .883 .786 .818 .950 .717 .714
p value .013 .002 .021 .004 .000 .030 .047
Spearman's non-paratmetric correlation analysis of 16:1/16:0 and 18:1/18:0 with BMI & AI. P ≤ 0.05 was considered significant.Publish with BioMed Central    and   every 
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[15]. Very recently, in subjects with familial combined
hyperlipidemia (FCHL) and fatty acid desaturation index,
a significant heritable trait has been correlated with dysli-
pidemia [7]. Interestingly, in human subjects, positive
correlation between the SCD1 activity and hypertriglycer-
idemia has been reported [6]. In agreement with this,
recently, we related the over-expression of hepatic SCD1,
hypertriglyceridemia and desaturation index in obese rats
of WNIN/Ob strain [10]. In line with previous reports, in
the present study, in general, both BMI and AI positively
correlated with desaturation index. Further, different tis-
sues showed the correlation at different levels either with
BMI or AI and a few of them did not. However, the con-
sistent observation of the present study is that the plasma
fatty acid Δ9 desaturation index (both16:1/16:0 and 18:1/
18:0) exhibited strong positive correlation with the BMI
and AI of rats of both WNIN/Ob and WNIN/GR-Ob
strains. Hence, the current data suggest that Δ9 desatura-
tion index of plasma fatty acids is a sensitive biochemical
parameter that correlates with BMI and AI, besides hyper-
triglyceridemia, dyslipidemia and metabolic syndrome.
Conclusion
In conclusion, plasma fatty acid Δ9 desaturation index; a
reflection of SCD1 activity is positively correlated with the
BMI and AI in the rats of both WNIN/Ob and WNIN/GR-
Ob strains. Therefore, this can be used as a simple sensi-
tive biochemical marker not only to assess the degree of
obesity, hypertriglyceridemia, but also to evaluate the effi-
cacy of certain anti-obesity agents.
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